Clinical Trials Logo

Filter by:
NCT ID: NCT05861375 Recruiting - Anorexia Nervosa Clinical Trials

Liver Biomarkers in Anorexia Nervosa

LIBAN
Start date: June 23, 2023
Phase:
Study type: Observational

The main goal of the Liver Biomarkers in Anorexia Nervosa (LIBAN) study is to determine the prevalence of liver fibrosis in patient with Anorexia Nervosa.

NCT ID: NCT05861037 Completed - Child, Only Clinical Trials

Thoracoscopy for Idiopathic Pneumothorax in Children

PNOPED
Start date: November 1, 2022
Phase:
Study type: Observational

The goal of this retrospective study is to describe the outcomes of spontaneous idiopathic pneumothorax treated by thoracoscopy with pleural abrasion and blebectomy. The main questions it aims to answer are: - are there risk factors leading to pneumothorax recurrence? - are pleural abrasion and blebectomy really diminishing the recurrence of pneumothorax?

NCT ID: NCT05861024 Completed - Child, Only Clinical Trials

Urinary Calculi After Bladder Augmentation in Children

LITAVPED
Start date: November 20, 2022
Phase:
Study type: Observational

The goal of this observational study is to analyse the occurence of urinary calculi after bladder augmentation in children: - location of the calculi (kidney or bladder) - type of bladder augmentation with higher rate of urinary calculi and why - Find risk factors of urinary calculi in bladder augmentation (age, sex, other bladder procedures..)

NCT ID: NCT05861011 Completed - Neurogenic Bladder Clinical Trials

Bladder Neck Surgery in Children With Neurogenic Bladder

CERPED
Start date: January 1, 2020
Phase:
Study type: Observational

Surgical outcomes of bladder neck surgery in children with neurogenic bladder. Consequences on bladder voiding.

NCT ID: NCT05860894 Recruiting - Atrial Fibrillation Clinical Trials

Post Intensive Care Unit Atrial Fibrillation

PIAF
Start date: September 19, 2023
Phase: N/A
Study type: Interventional

Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.

NCT ID: NCT05860699 Not yet recruiting - Clinical trials for Severe Alcohol Use Disorder (DSM 5)

Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH

CBD-OH
Start date: June 2024
Phase: Phase 2
Study type: Interventional

Randomized clinical trial of 10 days Cannabidiol versus placebo as an adjunctive treatment during inpatient alcohol detoxification to improve abstinence in patients with severe alcohol use disorder.

NCT ID: NCT05860660 Completed - Clinical trials for Internet Addiction Disorder

Screens, Virtual Reality and Digital Addiction (EVADD)

EVADD
Start date: July 20, 2023
Phase:
Study type: Observational

This is an observational study questionnaire-based. This study will be carried out to evaluate the methods of consumption (work/outside work), the characteristics of the tools used, the addictive risk, the consequences on mental and physical health and the impact on quality of life of people exposed to screens and smartphones. A sample of 800 000 people will be used to learn about the entire French population. Participants will be asked to respond to an anonymous digital survey. The ultimate goal of this work is to have quality information to help facilitate therapeutic efforts in support of those who may need it.

NCT ID: NCT05860244 Not yet recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients

WALKALS
Start date: September 2024
Phase: Phase 2
Study type: Interventional

Preclinical and clinical data strongly suggest that administration of salbutamol in ALS patients may improve walking capacity related to motor fatigue by enhancing neuromuscular transmission. Salbutamol may exert a neuroprotective effect and slow down the progression of clinical signs and symptoms. The main objective of the study is to test the efficacy of salbutamol on walking capacity in ALS patients and the secondary objective is to measure the target engagement of salbutamol on the neuromuscular junction (NMJ) at EMG (decrement of repetitive nerve stimulation in three nerves/muscle couples), as well as safety and tolerability. The exploratory objectives are to study the effect of salbutamol on fatigue scales, muscle strength, respiratory function, motor unit count, muscle and spinal MRI parameters and blood biomarkers

NCT ID: NCT05859191 Recruiting - Clinical trials for Systemic Lupus Erythematosus

Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus

FiNKLUPUS
Start date: July 21, 2023
Phase:
Study type: Observational

This study evaluates the variation of expression of the neonatal Fc receptor (FcRn) in Natural Killer T Cells Expressing an Invariant T Receptor (iNKT) and monocytes along with the surface expression of Fc gamma type II receptor (RII) and RIII in active or newly diagnosed lupus patients compared to inactive lupus patients.

NCT ID: NCT05858840 Completed - Child, Only Clinical Trials

Urinary Artificial Sphincter in Children

SUA
Start date: November 20, 2022
Phase:
Study type: Observational

Retrospective monocentric study of the outcomes of patients with neurogenic bladder, who had a urinary artificial sphincter before the age of 18 years old. Hypothesis: what was the impact of the urinary artificial sphincter on the global management of the patient.